Definitely a good thing, especially since Panno is very much on the ball as to making his observations clear and concise. Nothing has swayed me to sell. My only concern long term is the expiration of the graham patent. I hope benitec can get as many trials moving before that happens so that benitec is in the lead when it does expire, the problem is that a lot of companies can still work with ddRNAi under the safe harbor provision. Either way, benitec will still have a jump on ddRNAi.
News 
Market Data 
Discover 
